OHIOCARE "DOUBLE REBATE" THREAT FOR PRESCRIPTION DRUG PROGRAM
Executive Summary
OHIOCARE "DOUBLE REBATE" THREAT FOR PRESCRIPTION DRUG PROGRAM is one of the "most pressing [issues] that we have fight now as a company and in the industry," Johnson & Johnson Manager of State Government Affairs Don Bohn told a National Pharmacy Forum on State Health Care Reform Legislation in Pentagon City, Va. June 24. A pending Ohio program to move Medicaid patients into managed care organizations for medical care and pharmaceuticals includes one clause which could obligate rebates from manufacturers to the state as well as substantial discounts to the managed Care programs.